Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Exploring MFN Policy Effectiveness in Drug Pric...
By
João L. Carapinha
February 19, 2026
MFN Policy Effectiveness in Countering Freeloading Claims The MFN policy effectiveness is evident in the coalition letter dated February 12, 2026, which opposes codifying Mos...
Genotype ECG Prediction
Transformative PBM Reform Legislation Signed into Law
Late-Breaking Data on Bladder Cancer Treatments from KEYNOTE-B15 Trial
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
AstraZeneca Financial Results: Strong Revenue Growth and Pipeline Expansion i...
KEYTRUDA Ovarian Cancer Treatments: FDA Approves New Regimens for Platinum-Re...
Advancements in Uncertainty-Aware Diagnostics with ConfiDx LLM
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Healthcare Innovation Trends Shaping the Future: Insights from the J.P. Morga...
AI Healthcare Costs: Navigating Financial Hurdles in Technology Integration
Datroway Metastatic Breast Cancer: FDA Grants Priority Review for Breakthroug...
1
2
3
…
14
Next »